obipharma.com rank 314 |
Number of domains linking to obipharma.com 1 | semantic flow 0.07 |
Number of links to obipharma.com 1 | semantic flow 0.07 |
Number of domains linked from obipharma.com 1 | semantic flow 0.07 |
Number of links from obipharma.com 1 | semantic flow 0.07 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
http://www.obipharma.com/2017/07/licensing-agreement-of-thiobridge-signed-with-abzena-aim- obi pharma announces acquisition of th 3424 from threshold pharmaceuticals june 1 2017 ↳http://www.obipharma.com/2017/06/obi-pharma-announces-acquisition-of-th-3424-from-threshol | |
http://www.obipharma.com/2017/10/obi-pharma-announces-presentation-on-obi-3424-at-aacr-nci licensing agreement of thiobridge signed with abzena aim abza july 11 2017 ↳http://www.obipharma.com/2017/07/licensing-agreement-of-thiobridge-signed-with-abzena-aim- |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Licensing agreement of ThioBridgeâ„¢ signed with Abzena (AIM: ABZA) u2013 OBI Pharma http://www.obipharma.com/2017/07/licensing-agreement-of-thiobridge-signed-with-abzena-aim- | 0.28 | 0.99 | 43 | 18 | 1 | 1 | 0 | 0 | |
OBI Pharma Announces Presentation on OBI-3424 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics u2013 OBI http://www.obipharma.com/2017/10/obi-pharma-announces-presentation-on-obi-3424-at-aacr-nci | 0.28 | 0.95 | 43 | 18 | 1 | 1 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://biopharmguy.com/ | 1 | 0.07 | biopharmguy.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://blueswitch.com/ | 1 | 0.07 | blueswitch.com |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.obipharma.com/ | 1 | 0.15 | 0.95 | 0.07 | 1 | yes | 45 | 19 | 1 | 1 | 1 | 1 | |
http://www.obipharma.com/2017/12/obi-pharma-announces-participation-at-the-36th-j-p-morgan | 1 | 0.16 | 0.93 | 0.07 | 1 | yes | 43 | 17 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/pipeline/ | 1 | 0.16 | 0.93 | 0.07 | 0.99 | yes | 37 | 15 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/careers/ | 1 | 0.16 | 0.93 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.obipharma.com/2018/01/obi-pharma-announces-fda-clearance-of-ind-application-for | 1 | 0.16 | 0.92 | 0.06 | 0.96 | yes | 42 | 17 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/2017/10/obi-pharma-announces-obi-3424-results-from-the-aacr-nci-e | 1 | 0.16 | 0.92 | 0.06 | 0.93 | yes | 44 | 18 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/investors/corporate-governance/ | 1 | 0.16 | 0.92 | 0.06 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.obipharma.com/investors/shareholder-services/ | 1 | 0.16 | 0.92 | 0.06 | 0.69 | yes | 40 | 13 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/management/ | 1 | 0.16 | 0.72 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.obipharma.com/organizational-chart/ | 1 | 0.16 | 0.48 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.obipharma.com/ | 19 | 0.15 | 0.95 | 1.15 | 1 | yes | 45 | 19 | 1 | 1 | 1 | 1 | |
http://www.obipharma.com/investors/financial-report/ | 11 | 0.16 | 0.92 | 0.7 | 0.96 | yes | 48 | 26 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/2017/07/licensing-agreement-of-thiobridge-signed-with-abzena-aim- | 1 | 0.28 | 0.89 | 0.12 | 0.99 | yes | 43 | 18 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/2017/10/obi-pharma-announces-presentation-on-obi-3424-at-aacr-nci | 1 | 0.28 | 0.92 | 0.11 | 0.95 | yes | 43 | 18 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/author/ningc/ | 1 | 0.16 | 0.91 | 0.06 | 0.97 | yes | 47 | 20 | 1 | 1 | 0 | 0 | |
http://www.obipharma.com/2017/10/obi-pharma-announces-obi-3424-results-from-the-aacr-nci-e | 1 | 0.16 | 0.92 | 0.06 | 0.93 | yes | 44 | 18 | 1 | 1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.